mastheadart
Serving Jersey County Illinois

Custom Search
ADVERTISEMENT
120x600
Today's Health Photos
LONDON (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday.

COPENHAGEN (Reuters) - Drug maker Novo Nordisk said the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the use of its diabetes drug Tresiba for the treatment of children and adolescents.

LONDON (Reuters) - European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye.

MANILA (Reuters) - Philippine President Benigno Aquino has accepted the resignation of his health minister over the purchase of pneumonia vaccines in 2012 which government investigators later questioned, a spokesman said on Friday.

ZURICH/LONDON (Reuters) - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years.

MONROVIA (Reuters) - U.N. Secretary General Ban Ki-moon, starting a visit to Ebola-hit countries in West Africa, urged local communities to strictly follow health regulations in the face of signs that traditional funerals are still spreading the disease.

GENEVA (Reuters) - Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information.

BEIRUT (Reuters) - One million people have been wounded during Syria's civil war and diseases are spreading as regular supplies of medicine fail to reach patients, the World Health Organization's Syria representative said.

PARIS (Reuters) - U.S. drugmaker Eli Lilly and French biotech Adocia said on Friday they agreed a worldwide licensing partnership to develop an ultra-rapid insulin to treat patients with Type 1 and Type 2 diabetes.

TOKYO (Reuters) - A disgraced Japanese researcher has failed to replicate results hailed as a potential breakthrough in stem-cell treatment and efforts to do so will be abandoned, officials at her research institute said on Friday.

Login to access your GTI Webmail Account
Username:@
Password:
 Remember Remember me 
Not a member? Click Here
Browse RSS Feeds
click here when finished
Save Page Layout
Video
ADVERTISEMENT
loading